XNAS:ZOLT Quarterly Report 10-Q Filing - 6/30/2012

Effective Date 6/30/2012

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC   20549

FORM 10-Q
(Mark one)
[X]                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the three months ended June 30, 2012
OR

[  ]                 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from ___________ to ___________

Commission File No. 0-20600

ZOLTEK COMPANIES, INC.
(Exact name of registrant as specified in its charter)
 
Missouri
43-1311101
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)
   
3101 McKelvey Road, St. Louis, Missouri
63044
(Address of principal executive offices)
(Zip Code)
 
Registrant's telephone number, including area code:  (314) 291-5110

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes X    No __

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
 Yes  X    No __

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, non-accelerated filer or a smaller reporting company.  See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (check one).
Large Accelerated Filer ____ Accelerated Filer   X          Non-accelerated Filer ____ Smaller Reporting Company ____

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes __ No   X                         

Indicate the number of shares outstanding of each of the registrant's classes of common stock as of the latest practicable date:  As of August 2, 2012, 34,355,192 shares of Common Stock, $.01 par value, were outstanding.

 
1

 

ZOLTEK COMPANIES, INC.
 INDEX
 
 
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements (Unaudited)
 
Condensed Consolidated Balance Sheets – June 30, 2012 and September 30, 2011
 
Condensed Consolidated Statements of Operations – Three Months and Nine Months Ended June 30, 2012 and 2011
 
Condensed Consolidated Statements of Comprehensive Income – Three Months and Nine Months Ended June 30, 2012 and 2011
 
Condensed Consolidated Statement of Changes in Shareholders’ Equity – Nine Months Ended June 30,2012
 
Condensed Consolidated Statements of Cash Flows –Nine Months Ended June 30, 2012 and 2011
 
Notes to Condensed Consolidated Financial Statements (Unaudited)
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Item 4.
Controls and Procedures
PART II. OTHER INFORMATION
Item 1.
Legal Proceedings
Item 5.
Other Information
Item 6.
Exhibits
SIGNATURES
EXHIBIT INDEX
 
 
2

 
 
PART I.  FINANCIAL INFORMATION

Item 1.  Financial Statements
 
ZOLTEK COMPANIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands, except share data)
 
   
(Unaudited)
June 30,
2012
   
September 30,
2011
 
Assets
           
Current assets:
           
Cash and cash equivalents
  $ 29,041     $ 16,980  
Accounts receivable, less allowance for doubtful accounts of $118 and $110
    37,840       30,350  
Inventories, net
    62,439       47,882  
VAT receivable
    5,948       5,970  
Other current assets
    3,275       5,968  
Total current assets
    138,543       107,150  
Property and equipment, net
    211,026       215,083  
Other assets
    441       63  
Total assets
  $ 350,010     $ 322,296  
                 
Liabilities and shareholders' equity
               
Current liabilities:
               
Borrowings under credit lines
  $ 3,344     $ 8,394  
Current maturities of long-term debt
    4,010       -  
Trade accounts payable
    11,135       13,643  
Accrued expenses and other liabilities
    8,700       7,925  
Construction payables
    1,996       1,027  
Total current liabilities
    29,185       30,989  
Long-term debt
    22,540       -  
Hungarian grant - allowance against future depreciation
    6,629       7,765  
Deferred tax liabilties
    1,862       1,855  
Liabilities carried at fair value
    348       140  
Total liabilities
    60,564       40,749  
Commitments and contingencies (see Note 7)
               
Shareholders' equity:
               
Preferred stock, $.01 par value, 1,000,000 shares authorized, no shares issued or outstanding
    -       -  
Common stock, $.01 par value, 50,000,000 shares authorized, 34,355,192 and 34,368,192 shares issued and outstanding at June 30, 2012 and September 30, 2011
    344       344  
Additional paid-in capital
    481,576       480,893  
Accumulated other comprehensive loss
    (52,940 )     (41,549 )
Accumulated deficit
    (139,534 )     (158,141 )
Total shareholders' equity
    289,446       281,547  
Total liabilities and shareholders' equity
  $ 350,010     $ 322,296  
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
 
 
3

 
 
ZOLTEK COMPANIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except share and per share data)
(Unaudited)
 
   
Three months ended June 30,
   
Nine months ended June 30,
 
   
2012
   
2011
   
2012
   
2011
 
                         
Net sales
  $ 48,078     $ 38,593     $ 142,138     $ 108,554  
Cost of sales
    36,800       34,141       106,714       97,578  
Gross profit
    11,278       4,452       35,424       10,976  
Application and development costs
    1,708       2,256       5,331       6,396  
Selling, general and administrative expenses
    3,168       3,445       9,771       10,320  
Operating income (loss)
    6,402       (1,249 )     20,322       (5,740 )
Other (expense) income:
                               
Interest expense, net
    (146 )     (28 )     (196 )     (69 )
(Loss) gain on foreign currency transactions
    (29 )     (860 )     282       (1,931 )
Other expense, net
    (577 )     (164 )     (807 )     (429 )
Gain on liabilities carried at fair value
    243       1,113       73       580  
Income (loss) from operations before income taxes
    5,893       (1,188 )     19,674       (7,589 )
Income tax expense
    327       273       1,067       541  
                                 
Net income (loss)
  $ 5,566     $ (1,461 )   $ 18,607     $ (8,130 )
                                 
Basic income (loss) per share
  $ 0.16     $ (0.04 )   $ 0.54     $ (0.24 )
Diluted income (loss) per share
  $ 0.16     $ (0.04 )   $ 0.54     $ (0.24 )
                                 
Weighted average common shares outstanding – basic
    34,355,192       34,373,137       34,359,433       34,381,690  
Weighted average common shares outstanding – diluted
    34,413,680       34,373,137       34,413,907       34,381,690  
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 
4

 
 
ZOLTEK COMPANIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Amounts in thousands)
(Unaudited)
 
   
Three months ended June 30,
   
Nine months ended June 30,
 
   
2012
   
2011
   
2012
   
2011
 
Net income (loss)
  $ 5,566     $ (1,461 )   $ 18,607     $ (8,130 )
Foreign currency translation adjustment
    (7,325 )     5,456       (11,043 )     15,477  
Change in unrealized fair value of cash flow hedge
    (348 )             (348 )        
                                 
Comprehensive (loss) income
  $ (2,107 )   $ 3,995     $ 7,216     $ 7,347  
 
 
 
ZOLTEK COMPANIES, INC.
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY
(Amounts in thousands)
(Unaudited)
 
   
Total Shareholders’ Equity
   
Common Stock
   
Additional Paid-In Capital
   
Accumulated Other Comprehensive Loss
   
Accumulated Deficit
 
Beginning Balance - September 30, 2011
  $ 281,547     $ 344     $ 480,893     $ (41,549 )   $ (158,141 )
                                         
Comprehensive income (loss)
    7,216                       (11,391 )     18,607  
Stock option expense
    665               665                  
Exercise of stock options
    4               4                  
Difference between compensation and change in liability for restricted stock awards
    14               14                  
                                         
Ending Balance - June 30, 2012
  $ 289,446     $ 344     $ 481,576     $ (52,940 )   $ (139,534 )
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
 
 
5

 

ZOLTEK COMPANIES, INC.
  CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
(Unaudited)
 
   
Nine months ended June 30,
 
   
2012
   
2011
 
Cash flows from operating activities:
           
Net income (loss)
  $ 18,607     $ (8,130 )
Adjustments to reconcile net income to net cash from operating activities:
               
Depreciation
    13,309       13,056  
Amortization of financing fees and debt discount
    11       -  
Deferred tax expense
    -       23  
Gain on liabilities carried at fair value
    (73 )     (580 )
Foreign currency transaction (gain) loss
    (379 )     2,326  
Stock compensation expense
    799       746  
Loss on disposal of assets
    646       239  
Changes in assets and liabilities:
               
Increase in accounts receivable
    (8,772 )     (4,547 )
Increase in inventories
    (16,392 )     (7,718 )
Decrease (increase) in other current assets and other assets
    2,143       (1,490 )
(Decrease) increase in trade accounts payable
    (1,864 )     2,314  
Increase in accrued expenses and other liabilities
    215       608  
Net cash provided by (used in) operations
    8,250       (3,153 )
                 
Cash flows from investing activities:
               
Purchases of property and equipment
    (18,010 )     (5,238 )
Increase in construction payables
    969       552  
Proceeds from sale of fixed assets
    -       24  
Proceeds received from Hungarian grant
    -       22  
Net cash used in investing activities
    (17,041 )     (4,640 )
                 
Cash flows from financing activities:
               
Payment of financing fees
    (269 )     -  
Proceeds from exercise of stock options
    4       -  
(Repayment) borrowing of credit lines
    (5,050 )     4,131  
Borrowings under notes payable
    26,524       -  
Cash settlement of restricted shares
    (114 )     (245 )
Cash settlement of stock options
    -       (35 )
Net cash provided by financing activities
    21,095       3,851  
Effect of exchange rate changes on cash and cash equivalents
    (243 )     (705 )
Net (decrease) increase in cash and cash equivalents
    12,061       (4,647 )
Cash and cash equivalents at beginning of period
    16,980       21,534  
Cash and cash equivalents at end of period
  $ 29,041     $ 16,887  
 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
 
 
6

 
 
ZOLTEK COMPANIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1.  ORGANIZATION AND BASIS OF PRESENTATION
 
            Zoltek Companies, Inc. is a holding company, which operates through wholly-owned subsidiaries, Zoltek Corporation, Zoltek Zrt., Zoltek de Mexico SA de CV, Zoltek de Occidente SA de CV, Engineering Technology Corporation (“Entec Composite Machines”), Zoltek Properties, Inc., and Zoltek Automotive, LLC. Zoltek Corporation (“Zoltek”) develops, manufactures and markets carbon fibers and related products, including carbon fibers preimpregnated with resin known as “prepreg,” and technical fibers in the United States. Carbon fibers are a low-cost but high performance reinforcement for composites used as the primary building material in everyday commercial products. Technical fibers are an intermediate product used in heat-resistant applications such as aircraft brakes. Zoltek Zrt. is a Hungarian subsidiary that manufactures and markets carbon fibers and technical fibers and manufactures acrylic fiber precursor raw material used in production of carbon fibers and technical fibers. Zoltek de Mexico SA de CV and Zoltek de Occidente SA de CV are Mexican subsidiaries that manufacture carbon fiber and precursor raw material. Entec Composite Machines manufactures and markets filament winding and pultrusion equipment used in the production of large volume composite parts. The Company primarily sells its products in Europe and the United States; however, the Company has an increasing sales presence in Asia. Unless the context otherwise indicates, references to the “Company” are to Zoltek Companies, Inc. and its subsidiaries.
 
Certain prior year amounts have been reclassified to conform to the current year presentation.

Basis of Presentation

The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements and should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2011, which includes consolidated financial statements and notes thereto. In the opinion of management, all normal recurring adjustments and estimates considered necessary have been included. The results of operations of any interim period are not necessarily indicative of the results that may be expected for a full fiscal year.

The unaudited interim condensed consolidated financial statements include the accounts and transactions of the Company and its wholly-owned subsidiaries. All significant inter-company transactions and balances have been eliminated in consolidation. Adjustments resulting from the currency translation of financial statements of the Company’s foreign subsidiaries are reflected in the condensed consolidated balance sheets as “Accumulated other comprehensive loss” within shareholders’ equity. Gains and losses from foreign currency transactions are included in the condensed consolidated statements of operations as “Other income (expense).”

Adoption of New Accounting Standards

See Note 11 of the Notes to Condensed Consolidated Financial Statements.

 
7

 
 
2.      INVENTORIES

 
Inventories, net of reserves, consist of the following (in thousands):
 
   
June 30,
2012
   
September 30,
2011
 
Raw materials
  $ 9,127     $ 7,447  
Work-in-process
    16,287       11,025  
Finished goods
    33,185       26,626  
Consigned inventory
    3,332       2,488  
Supplies and other
    508       296  
    $ 62,439     $ 47,882  
 
Inventories are valued at the lower of cost or market and are removed from inventory under the first-in-first-out method (“FIFO”). Cost of inventory includes material, labor and overhead. The Company recorded inventory valuation reserves of $0.4 million and $0.7 million as of June 30, 2012 and September 30, 2011, respectively, to reduce the carrying value of inventories to a net realizable value. Consigned inventory represents contractually required finished goods inventory levels for certain key customers.  If future demand or market conditions are less favorable than the Company’s projections, additional inventory write-downs may be required and would be reflected in cost of sales on the Company’s statement of operations in the period in which the determination is made.

3.      SEGMENT INFORMATION

 
The Company’s strategic business units are based on product lines and are comprised of three reportable segments: carbon fibers, technical fibers and corporate/other products. The carbon fibers segment manufactures commercial carbon fibers used as reinforcement material in composites and related products, including prepregs. The technical fibers segment manufactures oxidized acrylic fibers and specialty carbon fibers used to manufacture aircraft brake pads and for other heat/fire barrier applications. These two segments also facilitate development of product and process applications to increase the demand for carbon fibers and technical fibers. The carbon fibers and technical fibers segments’ production facilities are located geographically in the United States, Hungary and Mexico. The remaining business represented in the corporate/other products segment relates to water treatment and electrical services provided by the Hungarian operations and costs associated with the corporate headquarters.
 
 
8

 
 
Management evaluates the performance of its segments on the basis of operating income (loss) contribution. The following tables present financial information on the Company’s segments as of June 30, 2012 and September 30, 2011, and for the three and nine months ended June 30, 2012 and 2011 (in thousands):
 
   
Three months ended June 30, 2012
 
   
Carbon Fibers
   
Technical Fibers
   
Corporate/ Other
   
Total
 
Net sales
  $ 39,576     $ 7,854     $ 648     $ 48,078  
Cost of sales
    31,373       4,797       630       36,800  
Gross profit
    8,203       3,057       18       11,278  
Operating income (loss)
    6,754       2,780       (3,132 )     6,402  
Depreciation
    3,988       334       136       4,458  
Capital expenditures
    2,650       880       2,253       5,783  
 
   
Three months ended June 30, 2011
 
   
Carbon Fibers
   
Technical Fibers
   
Corporate/ Other
   
Total
 
Net sales
  $ 29,454     $ 8,552     $ 587     $ 38,593  
Cost of sales
    26,049       7,595       497       34,141  
Gross profit
    3,405       957       90       4,452  
Operating income (loss)
    1,350       728       (3,327 )     (1,249 )
Depreciation
    4,061       365       135       4,561  
Capital expenditures
    2,097       78       177       2,352  
 
   
Nine months ended June 30, 2012
 
   
Carbon Fibers
   
Technical Fibers
   
Corporate/ Other
   
Total
 
Net sales
  $ 115,199     $ 25,168     $ 1,771     $ 142,138  
Cost of sales
    89,118       15,902       1,694       106,714  
Gross profit
    26,081       9,266       77       35,424  
Operating income (loss)
    21,217       8,306       (9,201 )     20,322  
Depreciation
    11,933       995       381       13,309  
Capital expenditures
    14,163       1,131       2,716       18,010  
 
   
Nine months ended June 30, 2011
 
   
Carbon Fibers
   
Technical Fibers
   
Corporate/ Other
   
Total
 
Net sales
  $ 84,642     $ 22,346     $ 1,566     $ 108,554  
Cost of sales
    77,049       19,537       992       97,578  
Gross profit
    7,593       2,809       574       10,976  
Operating income (loss)
    1,374       2,025       (9,139 )     (5,740 )
Depreciation
    11,405       1,057       594       13,056  
Capital expenditures
    4,086       527       625       5,238  
 
   
Total Assets
 
   
Carbon Fibers
 
Technical Fibers
 
Corporate/ Other
 
Total
 
June 30, 2012
  $ 287,366     $ 29,778     $ 32,866     $ 350,010  
September 30, 2011
  $ 272,397     $ 28,789     $ 21,110     $ 322,296  
 
 
9

 

4.     EARNINGS PER SHARE

 
In accordance with Accounting Standards Codification (“ASC”) 260, the Company has evaluated its diluted income (loss) per share calculation. The Company had outstanding warrants and stock options at June 30, 2012 and 2011 which were not included in the determination of diluted income (loss) per share because they were anti-dilutive.

Net income (loss) per share for the three and nine months ended June 30, 2012 and 2011, respectively, was as follows (in thousands, except per share amounts):

   
Three months ended June 30,
   
Nine months ended June 30,
 
   
2012
   
2011
   
2012
   
2011
 
Numerators:
                       
Net income (loss)
  $ 5,566     $ (1,461 )   $ 18,607     $ (8,130 )
                                 
Denominators:
                               
Average shares outstanding – basic
    34,355       34,373       34,359       34,382  
Impact of stock options
    59       -       55       -  
Average shares outstanding – diluted
    34,414       34,373       34,414       34,382  
                                 
Basic income (loss) per share
  $ 0.16     $ (0.04 )   $ 0.54     $ (0.24 )
Diluted income (loss) per share
  $ 0.16     $ (0.04 )   $ 0.54     $ (0.24 )
 
 
5.     FINANCING TRANSACTIONS

 
HUNGARIAN GRANT
 
The Hungarian government has pledged a grant of 2.9 billion HUF to Zoltek’s Hungarian subsidiary, which translated at the June 30, 2012 exchange rate, was approximately $12.4 million. The grant has provided a portion of the capital resources necessary to modernize the subsidiary’s facility, establish a research and development center, and support buildup of manufacturing capacity of carbon fibers. As of June 30, 2012, Zoltek’s Hungarian subsidiary has received approximately 2.6 billion HUF ($11.2 million at the June 30, 2012 exchange rate) in grant funding. These funds have been recorded as a liability on the Company’s consolidated balance sheet. The liability is being amortized over the life of the assets procured by the grant funds, offsetting the depreciation expense from the assets into which the proceeds of the grant are invested. As required by the grant, the Company has issued bank guarantees amounting to 120% of the amount of the grant as received.
 
The Hungarian subsidiary may be required to repay all or a portion of the grant if, among other things, the Hungarian subsidiary:  fails to obtain revenue targets; fails to employ an average annual staff of at least 1,200 employees; fails to utilize regional suppliers for at least 45% of its purchases; fails to obtain consent from the Hungarian government prior to selling assets created with grant funds; fails to use grant funds in accordance with the grant agreement; fails to provide appropriate security for the grant; makes or made an untrue statement or supplies or supplied false data in the grant agreement, grant application or during the time of the grant; defaults on its obligations by more than 30 days; withdraws any consents it gave in the grant agreement; or causes a partial or complete failure or hindrance of the project that is the subject of the grant. These targets must be achieved during a five-year measurement period from October 2012 to October 2017, though the Company has received a letter of intent from the Hungarian government to delay the beginning of the five-year measurement period by one year. Although there can be no assurance, the Company anticipates it will comply with the requirements of the grant agreement when the measurement period begins.
 
FINANCING ACTIVITY
 
Hungarian Financing
 
On June 15, 2012, Zoltek’s Hungarian subsidiary (“Zoltek Zrt”) completed an amended credit facility with Raiffeisen Bank Zrt. (the “Lender”) pursuant to which Zoltek Zrt. and the Lender entered into a Credit Facility Agreement, dated as of June 1, 2012, and a Restated and Amended Uncommitted Credit Line Agreement, dated as of June 1, 2012.  Under the credit facility, the Lender agreed to provide Zoltek Zrt.: (1) a term facility in the maximum amount of 13.6 million EUR ($17.1 million at the June 30, 2012 exchange rate) (the “Term Facility”) and (2) a multicurrency overdraft facility in the amount of up to 1.12 billion HUF ($4.8 million at the June 30, 2012 exchange rate) (the “Revolving Facility”).
 
 
10

 
 
The Term Facility is a five-year term loan and bears interest at 4.17%, payable semi-annually.  Principal under the Term Facility is payable semi-annually in equal installments.  The Revolving Facility is a revolving credit facility that expires on March 29, 2013 and has a total commitment of 1.120 billion HUF ($4.8 million at the June 30, 2012 exchange rate) subject to a borrowing base.  In addition to the Term Facility and the Revolving Facility, Zoltek Zrt. has obtained from the lender a bank guaranty in the amount of HUF 3.48 billion ($14.9 million at the June 30, 2012 exchange rate) as required by the Hungarian government grant.  The obligations of Zoltek Zrt. under this credit facility are guaranteed by the Company.
 
This credit facility contains representations and warranties, and contains a requirement that Zoltek Zrt. maintain a minimum current asset ratio and minimum annual EBITDA, along with other covenants.  Zoltek Zrt. had previously maintained a credit facility with the Lender, which expired May 30, 2012 and the facility was replaced with the new facility.
 
US Financing

On March 30, 2012, Zoltek Companies, Inc. entered into a $10 million term loan with Enterprise Bank & Trust (the “Enterprise Loan”) secured by the real property associated with its facilities in the St. Louis, Missouri area.  The Enterprise Loan is a seven-year, secured term loan maturing March 30, 2019. Principal of the Enterprise Loan is payable monthly with a balloon payment due at maturity. The Enterprise Loan bears interest at a one-month LIBOR rate, plus 3%. The Company entered into a swap agreement that fixes the interest rate on the Enterprise Loan at 4.75% per annum. The Loan Agreement contains representations and warranties, and contains a requirement that the Company, on a consolidated basis, maintain minimum fixed charge coverage and leverage ratios, along with other covenants.
 
The Company primarily utilized the proceeds of the Enterprise Loan to repay all outstanding balances under the Company's former U.S. revolving credit facility with BMO Harris Bank N.A.

On April 27, 2012, Zoltek Companies, Inc. entered into a $15 million revolving credit agreement with JPMorgan Chase, N.A., with interest based on LIBOR plus 2.5%, adjusted monthly.  The revolving credit facility is subject to a borrowing base and financial covenants and expires on April 27, 2015.

6.     STOCK COMPENSATION EXPENSE

 
The Company maintains long-term incentive plans that authorize the Board of Directors or its Compensation Committee (the “Committee”) to grant key employees, officers and directors of the Company incentive or nonqualified stock options, stock appreciation rights, performance shares, restricted shares and performance units. The Committee determines the prices and terms at which awards may be granted along with the duration of the restriction periods and performance targets. All issuances are granted out of authorized but unissued shares, as the Company has no treasury stock. The Company has the option, in its sole discretion, to settle awards under its 2008 incentive plans in cash, in lieu of issuing shares.

The Company has two Long-Term Incentive Plans under which equity-based awards may be granted. At June 30, 2012, there were an aggregate of 2.0 million shares authorized for issuance under these plans. Approximately 0.4 million and 0.1 million shares remained available for future issuance under the 2008 Employee Long-Term Incentive Plan and the 2008 Directors Long-Term Incentive Plan, respectively.

Stock option awards.  During the first quarter of fiscal 2012 the Company awarded performance-based based stock options with separate performance conditions for vesting in respect of the Company’s results and to individual performances in fiscal years 2012, 2013, and 2014, to named executive officers and other key employees. The Company will recognize compensation expense related to each separate service period during the applicable period. The maximum number of performance-based options available to vest subject to certain operating performance targets is 1,158,750. The number of options available to vest are subject to the performance measures in a given fiscal year.   The Company determined that a grant date, for purposes of measuring compensation expense in accordance with US GAAP, has been established for all three performance years as a mutual understanding of key terms and conditions was demonstrated.  Also, during the first quarter of fiscal 2012, the Company granted 105,000 stock options with a vesting period through December 2012 to certain key employees.

              Annually, options to purchase 7,500 shares of common stock are issued to each director, other than the CEO, with an exercise price equal to the fair market value of the shares. In addition, newly elected directors receive options to purchase 7,500 shares of common stock. All such options vest immediately at time of grant.  Directors were issued options to purchase 37,500 shares of common stock at an exercise price of $14.58 during the nine months ended June 30, 2012.
 
 
11

 
 
The following table summarizes information for options currently outstanding and exercisable at June 30, 2012:
 
   
Options Outstanding
   
Options Exercisable
 
Range of Exercise Prices  
Number
 
Wtd. Avg. Remaining Life
 
Wtd. Avg. Exercise Price
   
Number
   
Wtd. Avg. Exercise Price
 
 $ 2.07 -
5.72
    1,218,750  
9 years
  $ 5.71       30,000     $ 5.47  
 8.40 -
8.60
    80,087  
3 years
    8.53       80,087       8.53  
 11.94 -
24.12
    122,500  
4 years
    15.73       111,250       15.22  
 31.07 -
36.73
    75,000  
3 years
    33.33       75,000       33.33  
 $ 2.07 -
36.73
    1,496,337                 296,337          
 
Presented below is a summary of stock option plans activity for the nine months ended June 30, 2012:
 
   
Options
 
Outstanding at September 30, 2011
    414,587  
Granted
    1,301,250  
Exercised
    (2,000 )
Forfeited or expired
    (217,500 )
Outstanding at June 30, 2012
    1,496,337  
Exercisable at June 30, 2012
    296,337  
 
The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the following assumptions:
 
Assumptions
  Fiscal 2012    
Fiscal 2011
   
Fiscal 2010
   
Fiscal 2009
   
Fiscal 2008
 
Expected life of option (years)
  3 -
5
   
5
   
3.8
    3.8 &
4
 
  4 &
 7.5
 
Risk-free interest rate
  0.4% - 0.8%     2.4%     0.4%       0.5%         1.8%    
Volatility of stock
  72% - 79%     73%     77%       79%         66%    
Forfeiture rate
  0% - 16%     0%     0%     0% - 25%     0% - 30%  
 
Volatility, expected term and dividend yield assumptions were based on the Company’s historical experience. The risk-free rate was based on a U.S. treasury note with a maturity similar to the option grant’s expected term. The number of options used to recognize expense for performance-based shares is based on the probable established performance target expected to be achieved as of the end of the period.

Restricted stock awards. Under the Company’s equity incentive plans, employees and directors may be granted restricted stock awards with participation rights which are valued based upon the fair market value on the date of the grant. The balance of restricted stock shares outstanding was 15,000 shares as of June 30, 2012.

During the first quarter of fiscal 2012, 15,000 restricted shares became subject to vesting.   The Company opted to settle the shares in cash of $0.1 million in lieu of issuing shares. In accordance with ASC 718, the Company determined its practice of settling vested restricted shares in cash resulted in a modification from equity to liability accounting in fiscal 2010 for the remaining unvested restricted shares. The fair value of the modified liability award is measured each reporting date through settlement and any adjustments to increase or decrease the liability are recorded either as compensation cost or a charge to equity.
 
The Company recorded into selling and general administrative expense for its corporate/other products segment the cost of employee services received in exchange for equity instruments based on the grant-date fair value of those instruments in accordance with the provisions of ASC 718, which was $0.1 million and $0.8 million for the three and nine months ended June 30, 2012, and less than $0.1 million and $0.7 million for the three months and nine months ended June 30, 2011. There were no tax benefits recognized during the nine months ended June 30, 2012 or 2011, as any benefit is offset by the Company's full valuation allowance on its net deferred tax asset.
 
 
12

 
 
7.   COMMITMENTS AND CONTINGENCIES

 
CONCENTRATION OF CREDIT
 
Zoltek's carbon fiber products are primarily sold to customers in the wind energy and composite industries and its technical fibers are primarily sold to customers in the aerospace industry. Entec Composite Machines’ products are primarily sold in the composite industry. The Company performs ongoing credit evaluations and generally requires collateral for significant export sales to new customers. The Company maintains reserves for potential credit losses and such losses have been within management's expectations.

In the three months ended June 30, 2012 and 2011, the Company reported aggregate sales of $24.1 million and $10.2 million, respectively, to Vestas Wind Systems, a leading wind turbine manufacturer. In the nine months ended June 30, 2012 and 2011, the Company reported aggregate sales of $64.1 million and $27.4 million, respectively, to Vestas Wind Systems.  In the three and nine months ended June 30, 2011, the Company reported aggregate sales of $4.9 million and $14.5 million, respectively, to a manufacturer of fabrics for the composite industry, including materials for production of wind turbines. In the nine months ended June 30, 2011, the Company reported aggregate sales of $12.8 million to  a manufacturer of composite materials for the offshore oil and gas industries.  These were the only customers that represented greater than 10% of consolidated net sales in these periods.

ENVIRONMENTAL
 
The Company's operations generate various hazardous wastes, including gaseous, liquid and solid materials. The operations of the Company's carbon fibers and technical fibers business segments utilize thermal oxidation of various by-product streams designed to comply with applicable laws and regulations. The plants produce air emissions that are regulated and permitted by various environmental authorities. The plants are required to verify by performance tests that certain emission rates are not exceeded. The Company does not believe that compliance by its carbon fibers and technical fibers operations with applicable environmental regulations will have a material adverse effect upon the Company's future capital expenditure requirements, results of operations or competitive position. There can be no assurance, however, as to the effect of interpretation of current laws or future changes in federal, state or international environmental laws or regulations on the business segment's results of operations or financial condition.
 
SOURCES OF SUPPLY
 
As part of its growth strategy, the Company has developed and manufactures its own precursor acrylic fibers and all of its carbon fibers and technical fibers. The primary source of raw material for the precursor is ACN (acrylonitrile), which is a commodity product with multiple sources.
 
8.   INCOME TAXES

 
The Company currently has net operating loss carryforwards available to offset future tax liabilities. The Company has recorded a full valuation allowance against its deferred tax assets in Hungary, the United States and Mexico because it is more likely than not that the value of the deferred tax assets will not be realized. In the consolidated balance sheets, the Company classifies its deferred tax assets and liabilities as either current or non-current, according to the expected reversal date of the temporary differences as of the reporting date.
 
As of June 30, 2012, we had uncertain tax positions which may change as a result of the outcomes of audits. The Company tracks uncertain tax positions under the guidance of ASC 740-10.  Income tax expense was $0.3 million and $1.1 million for the three and nine months ended June 30, 2012, respectively, compared to an expense of $0.3 million and an expense of $0.5 million for the three and nine months ended June 30, 2011, respectively. In fiscal 2012, an expense of $1.0 million was incurred related to the local Hungarian municipality tax and less than $0.1 million was recorded related to U.S. and Mexico minimum tax payments.  During the first quarter of fiscal 2011, the Company recognized a $0.3 million expense as we adjusted our Hungarian effective tax rate to reflect a change to tax. The Hungarian tax rate of 10% applies to a tax base up to HUF 500 million (approximately $2.1 million using the June 30, 2012 exchange rate), with a 19% rate continuing to apply to a base exceeding this ceiling. Hungary has also announced that effective for the Company’s fiscal 2013 tax year, losses carried forward from previous years can be used only up to 50% of the tax base.  For the first nine months of fiscal 2011, income tax expense of $0.5 million was incurred related to the local Hungarian municipality tax and U.S. income taxes. A tax benefit of approximately $0.2 million was recorded related to an increase in Hungary’s deferred tax position.
 
13

 

9.   FAIR VALUE MEASUREMENT OF INSTRUMENTS

 
Zoltek adopted ASC 820 on October 1, 2008.  ASC 820 defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.  The fair value hierarchy for disclosure of fair vale measurements under ASC 820 is as follows:
 
Level 1 – Valuations based on quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.
 
Level 2 – Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
 
Interest Rate Swap

On March 30, 2012, the Company entered into an interest rate swap agreement that fixes the interest rate on its term loan in order to manage the risk associated with changes in interest rates.  This interest rate derivative instrument has been designated as a cash flow hedge of our expected interest payments under the FASB’s ASC Topic 815, Derivatives and Hedging. This instrument effectively converts variable interest payments on the term loan into fixed payments. In a cash flow hedge, the effective portion of the change in fair value of the hedging derivative is recorded in accumulated other comprehensive income (loss) and is subsequently reclassified into earnings during the same period in which the hedged item affects earnings.    The change in fair value of any ineffective portion of the hedging derivative is recognized immediately in earnings.  The fair value of the interest rate swap is determined using an internal valuation model which relies on the expected LIBOR yield curve and estimates of counterparty and the Company’s non-performance risk as the most significant inputs.  Because each of these inputs are directly observable or can be corroborated by observable market data, we have categorized the interest rate swap as Level 2 within the fair value hierarchy.

Warrants and Restricted Shares
 
The Company adopted ASC 815-40 on October 1, 2009.  In connection with the adoption, the Company determined that its outstanding warrants as of the adoption date, which include warrants issued in May 2006, July 2006, October 2006, and December 2006, are not indexed to the Company’s own stock.  Accordingly, these warrants should be treated as a fair value liability, which requires separate accounting pursuant to ASC 815-40.  The fair value of the warrants was reclassified from equity to a fair value liability on October 1, 2009.
 
The Company used a Black-Scholes pricing model to determine the fair value of the warrants.  Fair values under the Black-Scholes model are partially based on the expected remaining life of the warrants, which is an unobservable input.  Therefore, we have deemed the fair value liability associated with the outstanding warrants to have Level 3 inputs.  If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

The fair value of the warrants is determined using the Black-Scholes option-pricing model with the following weighted average assumptions as of June 30, 2012:
 
Outstanding Warrant Issuances
 
   
Issued
December 2006
 
Warrants issued (in shares)
 
827,789
 
Expiration of warrants
 
December 2012
 
Per share exercise price of warrants
  $ 28.06  
Expected remaining life of warrants (in years)
    0.46  
Risk-free interest rate
    0.14 %
Stock volatility
    72.28 %
Dividend yield
    0.00 %
 
The fair value of the restricted shares is determined using the current market price for the shares and an estimated forfeiture rate, an unobservable input.  At each balance sheet date, the Company adjusts unobservable inputs.  Although the market price of the shares is based on quoted market prices in an active market, the forfeiture rate is considered to be a significant input and therefore we have deemed the liability associated with the restricted shares to be Level 3.
 
 
14

 
 
The fair value of warrants, restricted shares, and the interest rate swap as of June 30, 2012 and September 30, 2011, was as follows (amounts in thousands, except per share amounts):
 
               
Fair Value Measurement
 
Liabilities:
 
Fair Value Per Share
   
Shares Issuable Upon Exercise
   
Total
   
Level 1
   
Level 2
   
Level 3
 
                                     
Warrants -- December 2006 Issuance
                               
As of June 30, 2012
  $ 0.03       827,789     $ 21     $ -     $ -     $ 21  
As of September 30, 2011
    0.11       827,789     $ 94     $ -     $ -     $ 94  
                                                 
Restricted Shares
                                               
As of June 30, 2012
                  $ 97     $ -     $ -     $ 97  
As of September 30, 2011
                  $ 92     $ -     $ -     $ 92  
                                                 
Interest Rate Swap
                                               
As of June 30, 2012
                  $ 348     $ -     $ 348     $ -  
As of September 30, 2011
                  $ -     $ -     $ -     $ -  
 
During the first quarter of fiscal 2012, 102,835 warrants expired. The fair value liability balance of warrants decreased by $0.2 million and $0.1 million during the third quarter and first nine months of fiscal 2012, respectively, related to a decrease in expected life during the first nine months of fiscal 2012. The restricted shares balance increased by less than $0.1 million related to an increase in fair value offset by the settlement of $0.1 million (15,000 shares) that vested during the first quarter, for a total balance of $0.1 million at June 30, 2012, from $0.1 million at September 30, 2011. The balance of restricted stock outstanding was 15,000 shares at June 30, 2012.  Both the warrant and restricted stock fair value balances are recorded as short term liabilities in “Accrued expenses and other liabilities” on the balance sheet.  The interest rate swap balance increased by $0.3 million related to an increase in fair value.  The interest rate swap balance is recorded as a long term liability in “Liabilities carried at fair value” on the balance sheet.
 
Derivatives designated as hedging instruments
 
Change in Unrealized Gain (Loss) Recognized in Accumulated Other Comprehensive Loss
 
       
Interest Rate Swap
     
       
Nine months ended June 30, 2012
  $ (348 )
Nine months ended June 30, 2011
  $ -  
 
As of June 30, 2012, no deferred gains or losses are expected to be reclassified into earnings as interest expense related to the interest rate swap over the next twelve months as its critical terms matched those of the term loan at inception and through June 30, 2012.
 
10.      FOREIGN CURRENCY TRANSLATION

 
The Company’s Hungarian subsidiary, Zoltek Zrt. has a functional currency of the Hungarian Forints (HUF). As a result, the Company is exposed to foreign currency risks related to this investment. The consolidated balance sheet of Zoltek Zrt. was translated from HUF to U.S. dollars, at the exchange rate in effect at the applicable balance sheet date, while its consolidated statements of operations were translated using the average exchange rates in effect for the periods presented.  The related translation adjustments are reported as other comprehensive income (loss) within shareholders’ equity.  Gains and losses from foreign currency transactions of Zoltek Zrt. are included in the results of operations as other income (expense). The HUF weakened by 8.3% against the U.S. dollar during the first nine months of fiscal 2012.   This currency fluctuation caused an increase of $11.0 million in our accumulated other comprehensive loss for the nine months ended June 30, 2012.
 
The functional currency of Zoltek de Mexico is the U.S. dollar.
 
 
15

 
 
11.           RECENT ACCOUNTING PRONOUNCEMENTS

 
In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2011-04, “Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs.” The amendments in this ASU generally represent clarification of Topic 820, but also include instances where a particular principle or requirement for measuring fair value or disclosing information about fair value measurements has changed. This update results in common principles and requirements for measuring fair value and for disclosing information about fair value measurements in accordance with GAAP and International Financial Reporting Standards (“IFRS”). The amendments are effective for interim and annual periods beginning after December 15, 2011 and are to be applied prospectively. The adoption of this amended guidance did not result in any material change to disclosure in the notes to the Company’s consolidated financial statements (see Note 9 for the disclosures required by this guidance).

               In June 2011, the FASB issued ASU No. 2011-05, “Comprehensive Income (Topic 220):  Presentation of Comprehensive Income.” This amends existing guidance by allowing only two options for presenting the components of net income and other comprehensive income: (1) in a single continuous financial statement (statement of comprehensive income), or (2) in two separate but consecutive financial statements (consisting of an income statement followed by a separate statement of other comprehensive income). Also, items that are reclassified from other comprehensive income to net income must be presented on the face of the financial statements. ASU No. 2011-05 requires retrospective application, The Company adopted this provision in the second quarter of fiscal 2012.
 
 
16

 
 
Item 2.     Management's Discussion and Analysis of Financial Condition and Results of Operations

General

Zoltek Companies, Inc. is an applied technology and advanced materials company. Our mission is to lead the commercialization of carbon fiber through our development of a price-competitive, high-performance reinforcement for composites used in a broad range of commercial products which we sell under the Panex® trade name. In addition to manufacturing carbon fiber, we produce an intermediate product, a stabilized and oxidized acrylic fiber used in flame- and heat-resistant applications which we sell under the Pyron® trade name. We were founded in 1988 and incorporated in Missouri.

We led the development of the carbon fiber commercialization concept and we believe we are the largest manufacturer primarily focused on producing low-cost carbon fibers for commercial applications. We have spent over 15 years developing and refining our proprietary technology and manufacturing processes and building capacity. Until fiscal 2004, the high cost of carbon fibers tended to preclude all but the most demanding applications, limiting carbon fiber use primarily to aerospace and sporting goods applications.
 
From 2005 to 2007, demand for carbon fibers used in aerospace and commercial manufacturing applications increased significantly. Airbus and Boeing initiated production of new generation aircraft utilizing carbon fiber composites in critical primary airframe structures (i.e., fuselage and wings). At about the same time, the adoption of carbon fibers in longer wind turbine blades created a new demand for commercial carbon fibers. The combination of these two developments triggered a significant divergence of the aerospace and commercial carbon fibers applications.
 
The adaptation of carbon fibers in wind turbine applications led to a dramatic increase in demand for our carbon fibers in fiscal 2006 and 2007. For a short time we strained to meet all of the demand from our wind energy customers. When we were capacity-constrained, potential customers understandably would not commit to new large-scale applications without demonstrated assurance of adequate future supplies. In view of these projections and general carbon fiber supply shortages, we embarked on an expedited capacity expansion which we substantially completed in fiscal 2008. As a result we now have sufficient capacity to meet demand from current wind energy customers and produce carbon fibers for additional large-scale applications.
 
Zoltek’s mission to commercialize carbon fibers has proven successful over the past several years, but the development of large volume applications has been constrained because converting commercial carbon fibers to a finished product depends to a large degree on a fragmented and inefficient supply chain. Consequently, we are taking the next step in the commercialization process. We are designing new equipment and developing new processing methods to support the commercialization strategy. We are expanding our downstream processing capacity with the goal of ultimately becoming the leading carbon fiber prepreg manufacturer over the next few years. The goal is to develop higher-throughput, lower-cost conversion methods designed to consolidate the supply chain and open new market applications. These value-added, or “composite intermediate” products and processes, are being developed by Zoltek’s research and development (R&D) group.
 
In 2010, Zoltek announced the formation of Zoltek Automotive, a subsidiary established to accelerate the incorporation of carbon fiber products into automotive applications. Zoltek Automotive supports the commercialization effort in the automotive applications, which we believe will ultimately be the largest user of carbon fibers. This group seeks to  incorporate new developments in process equipment and manufacturing techniques into the automotive manufacturing applications.
 
As a part of this effort, on March 27, 2012, Zoltek announced collaboration with Magna Exteriors and Interiors, an operating unit of Magna International, Inc.to develop carbon fiber sheet molding compounds for the automotive industry.  Magna  Incorporated, based in Aurora, Ontario, Canada, is the largest automotive parts manufacturer in North America.  The newly developed carbon fiber material combines Zoltek’s Panex 35 commercial carbon fiber with Magna’s EpicBlendSMC sheet molding compound formulations.  The new material will allow Magna to offer an expanded range of lightweight parts and sub-systems for automotive, commercial truck and other markets. Magna Exteriors and Interiors will sell the sheet molding compound directly to molders.
 
We are aggressively marketing to obtain new business in both existing and new applications. New applications tend to require relatively long sales cycles due to the qualification of carbon fibers into new product development manufacturing and engineering. Targeted application areas include wind energy, deep sea drilling, infrastructure, aerospace secondary structures, automotive and aircraft brakes. During 2010, we added additional sales personnel in Asia, focusing on markets in China, India and Korea and have begun to see some success through new customers and sales in those regions.
 
In order to manage our business, we focus on two separate business segments: carbon fibers and technical fibers (oxidized acrylic fibers). We also manage the corporate/other segment which consists of ancillary activities not directly related to the carbon fiber or technical fiber operations.
 
 
17

 
 
KEY PERFORMANCE INDICATORS
 
Our management monitors and analyzes several key performance indicators within each of these segments to manage our business and evaluate our financial and operating performance, including:
 
Revenue. In the short-term, management closely reviews the volume of product shipments and indicated customer requirements in order to forecast revenue and cash receipts. In the longer-term, management believes that revenue growth through new product applications is the best indicator of whether we are achieving our objective of commercializing carbon fiber. We expect that new applications, including those we are attempting to facilitate, will positively affect demand for our products.
 
Gross profit.  Our consolidated gross profit margins for the third quarter of fiscal 2012 and 2011 were 23.5% and 11.5%, respectively. Our consolidated gross profit margins for the first nine months of fiscal 2012 and 2011 were 24.9% and 10.1%, respectively. Management focuses on improving the gross profit over the long-term while leading the commercialization of carbon fiber and controlling associated costs. The Company’s strategy is to maintain available unused capacity that positions the Company to capture opportunities in emerging applications. Gross margin was positively impacted during fiscal 2012 by several factors. Production levels increased with improved sales as we brought our Mexican capacity online and increased output in Hungary. We also improved the efficiency of our operations which decreased production costs. During the first nine months of fiscal 2012, gross margin was negatively impacted by $2.1 million of available unused capacity cost compared to $9.8 million during the first nine months of fiscal 2011. Costs of our primary raw material used in manufacturing, ACN, also decreased by approximately 18% from the third quarter of fiscal 2011.
 
Operating expenses.  Our operating expenses are driven by headcount and related administrative costs, marketing costs, and research and development costs. We monitor headcount levels in specific geographic and operational areas.  We believe that research and development expenditures will be the primary means by which we can facilitate new product applications.
 
Cash flow from operating activities.  Operating activities generated cash of $8.3 million and used cash of $3.2 million in the first nine months of fiscal 2012 and 2011, respectively. The primary use of cash was growth in accounts receivables and inventory to support sales expansion. Management believes that operating cash flow is meaningful to investors because it provides a view of Zoltek with respect to sustainability of our ongoing operations and the extent to which we may or may not require external capital. It also provides meaningful insight into the management of our working capital.
 
Liquidity and cash flows.  Due to the variability in revenue, our cash position varies. We closely monitor our expected cash levels, particularly as they relate to operating cash flow, days’ sales outstanding, days’ payables outstanding and inventory turnover.

BUSINESS TRENDS
 
Zoltek management has focused its efforts on building on the long-term vision of Zoltek as the leader in commercialization of carbon fibers as a low-cost but high performance reinforcement for composites. Management primarily emphasizes the following areas:

 
·
Increased Sales Efforts in Selected International Markets. We have identified international markets with high growth potential for our existing and emerging commercial applications. Accordingly, we have added sales personnel and increased our marketing efforts in Asia. Indications are that global customer demand appears stronger for fiscal 2012.
 
 
·
Business Development in Emerging Applications.  We have identified emerging applications for our products with high growth potential across a variety of industries and regions. We have taken a major step toward growing our carbon fiber prepreg capabilities by opening a new 135,000 square foot facility outside of St. Louis, Missouri in November 2011. One of our goals is to leverage our leadership in commercial carbon fibers to become the leading provider of carbon fiber prepreg in the global marketplace over the next few years.  Our research and development center, to support our targeted applications with high volume manufacturing and processing technologies, will also be located at this new facility.
 
In addition to producing carbon fibers for the existing prepreg technology used by many of our large wind turbine customers, we have recently begun shipments of carbon fibers qualified for use in the infusion process utilized by certain wind turbine blade manufacturers.  We also are seeking to qualify our products for use in aerospace secondary structures such as floor, luggage bins and seats, and anticipate increased sales in this market as the production of new jetliners increases.
 
 
·
Operating Cash Flow and Cash Management.   Due to a 30.9% increase in sales, we reported positive operating cash flow of $8.3 million during the first nine months of fiscal 2012.  We reported negative operating cash flow of $3.2 million during the first nine months of fiscal 2011.  Cash was used to build working capital in anticipation of increased sales during fiscal 2012.  We also built raw materials inventories in anticipation of increased acrylonitrile prices. Cash used for inventory was $16.4 million and increased accounts receivable used cash of $8.8 million during the first nine months of fiscal 2012.  We have established collection targets and payment targets for all customers and suppliers to improve our days’ sales outstanding and days’ payables outstanding.  The Company reported $18.0 million of capital expenditures during the first nine months of fiscal 2012. The Company intends to utilize operating cash flow, currently existing credit lines and term loans in order to accommodate increases in working capital and capital expenditure requirements for the remainder of fiscal 2012.
 
 
·
Foreign Currency Volatility.  The HUF weakened against the U.S. dollar by 15.8% and the Mexican Peso weakened against the U.S. dollar by 8.8% during the first nine months of fiscal 2012 as compared to the first nine months of fiscal 2011. This resulted in lower processing cost and devaluation of inventory in the respective countries. The Euro weakened against the U.S. dollar by 5.2% during the first nine months of fiscal 2012 compared to the first nine months of fiscal 2011, resulting in decreased revenue. The Company’s financial statements will continue to be impacted by foreign currency volatility.
 
 
18

 
 
RESULTS OF OPERATIONS                                                      
 
THREE MONTHS ENDED JUNE 30, 2012 COMPARED TO THREE MONTHS ENDED JUNE 30, 2011
 
The Company's sales increased 24.6%, or $9.5 million, to $48.1 million in the third quarter of fiscal 2012 from $38.6 million in the third quarter of fiscal 2011.  During the third quarter of fiscal 2012, volume of product shipments increased 13.0% compared to the third quarter of fiscal 2011. Carbon fiber sales increased 34.4%, or $10.1 million, to $39.6 million in the third quarter of fiscal 2012 from $29.5 million in the third quarter of fiscal 2011 due primarily to increased shipments to wind customers. Technical fiber sales decreased 8.2%, or $.7 million, to $7.9 million in the third quarter of fiscal 2012 from $8.6 million in the third quarter of fiscal 2011 due primarily to decreased shipments to aircraft brake customers.  Additionally, the weakening of the Euro during the third quarter resulted in a $2.4 million decrease in total revenue.

The Company's cost of sales increased by 7.8%, or $2.7 million, to $36.8 million in the third quarter of fiscal 2012 from $34.1 million in the third quarter of fiscal 2011. The increase in cost of sales reflected increased sales of 24.6% discussed above and decreased raw material costs resulting primarily from lower ACN costs.  Carbon fiber cost of sales increased by 20.4%, or $5.4 million, to $31.4 million for the third quarter of fiscal 2012 from $26.0 million for the third quarter of fiscal 2011. The increase in carbon fiber cost of sales reflected increased sales of 34.4% as discussed above and decreased raw material resulting from lower ACN costs. Technical fiber cost of sales decreased by 36.8% or $2.8 million, to $4.8 million for the third quarter of fiscal 2012 from $7.6 million for the third quarter of fiscal 2011 as a result of improved efficiencies and lower cost ACN.

The Company's gross profit increased by $6.8 million, to $11.3 million, or 23.5% of sales in the third quarter of fiscal 2012 from $4.5 million, or 11.5% of sales in the third quarter of fiscal 2011. During the third quarter of fiscal 2012, available unused capacity costs decreased to $0.7 million compared to the third quarter of fiscal 2011 when gross margin was negatively impacted by $3.3 million of available unused capacity cost. Carbon fiber gross profit percentage increased to 20.7% for the third quarter of fiscal 2012 compared to 11.6% for the third quarter of fiscal 2011. Carbon fiber gross profit increased to $8.2 million from $3.4 million during these respective periods. The increases in carbon fiber gross profit and gross profit margin resulted primarily from increased production levels with improved sales as we brought our Mexican operation online and increased output in Hungary. We also improved the efficiency of our operations which decreased production costs. Costs of our primary raw material used in manufacturing, ACN,  also decreased by approximately 18% during the third quarter of fiscal 2012 from the third quarter of fiscal 2011. Technical fiber gross profit increased to $3.1 million, or 38.9% of sales, in the third quarter of fiscal 2012 from $1.0 million, or 11.2% of sales, in the third quarter of fiscal 2011. The increases in technical fiber gross profit and margin resulted from increased production output in Hungary and lower ACN cost.
 
Application and market development costs were $1.7 million for the third quarter of fiscal 2012 and $2.3 million for the third quarter of fiscal 2011. These costs included product development efforts, product trials and operational improvement design. Targeted emerging applications include automobile components, offshore oil and gas drilling, fire/heat barrier and alternate energy technologies.  The third quarter of fiscal 2011 included consulting costs for automotive market development and developmental costs for our prepreg materials, which were not incurred in the third quarter of fiscal 2012.
 
Selling, general and administrative expenses decreased to $3.2 million in the third quarter of fiscal 2012 compared to $3.4 million in the third quarter of fiscal 2011. The Company recorded $0.1 million for the cost of employee and director services received in exchange for equity instruments under ASC 718 during the third quarter of fiscal 2012, an increase of $0.1 million from the expense of less than $0.1 million in the third quarter of fiscal 2011.
 
Operating income from the third quarter of fiscal 2012 was $6.4 million, an improvement from an operating loss of $1.2 million incurred during the third quarter of fiscal 2011. This improvement resulted primarily from an increase in gross profit of $6.8 million, as discussed above.  Carbon fiber operating income increased to $6.8 million in the third quarter of fiscal 2012 from income of $1.4 million in the third quarter of fiscal 2011. The increase resulted from an increase in gross profit as discussed above.  Operating income from Technical fiber increased to $2.8 million in the third quarter of fiscal 2012 from $0.7 million in the third quarter of fiscal 2011. The increase in technical fiber operating income resulted primarily from the increase in gross profit described above.
 
Loss on foreign currency translations was less than $0.1 million in the third quarter of fiscal 2012, compared to a loss of $0.9 million for the third quarter of fiscal 2011. During the three months ended June 30, 2012 and 2011, the Euro weakened and the U.S. dollar strengthened in value against the HUF.  As most of the Company’s Hungarian accounts receivables are denominated in Euros and U.S. dollars, the combined effect of the weakening in value of the Euro and the strengthening in value of the U.S. dollar resulted in a small loss recognized at our Hungarian subsidiary.  The translation of the Hungarian subsidiary’s financial statements from its functional currency (HUF) to U.S. dollars is not included in determining net income for the period but is recorded in accumulated other comprehensive income (loss) in equity.
 
Other expense, net, was $0.6 million in the third quarter of fiscal 2012 compared to $0.2 million in the third quarter of fiscal 2011. Other expense, net consists primarily of non-operating costs and losses from the disposal of fixed assets.
 
Gain on liabilities carried at fair value was $0.2 million in the third quarter of fiscal 2012 compared to a $1.1 million gain in the third quarter of fiscal 2011 (see   “ Liquidity and Capital Resources – Fair Value Measurement of Instruments ").
 
 
19

 
 
Income tax expense was $0.3 million in both the third quarter of fiscal 2012 and the third quarter of fiscal 2011.  In fiscal 2012, this expense related to the local Hungarian municipality tax and less than $0.1 million was recorded related to U.S. and Mexico minimum tax payments.  During the third quarter of fiscal 2011, $0.1 million of expense was incurred related to the local Hungarian municipality tax and less than $0.1 million of expense was recorded related to U.S. and Mexico minimum tax payments. Additionally, in that quarter a tax expense of approximately $0.2 million was recorded related to an increase in Hungary’s deferred tax position.
 
The foregoing resulted in net income of $5.6 million for the third quarter of fiscal 2012 compared to a loss of $1.5 million for third quarter of fiscal 2011. Similarly, the Company reported income per share of $0.16 and loss per share of $0.04 per share on a basic and diluted basis for the third quarter of fiscal 2012 and 2011, respectively.

 
NINE MONTHS ENDED JUNE 30, 2012 COMPARED TO NINE MONTHS ENDED JUNE 30, 2011
 
The Company's sales increased 30.9%, or $33.6 million, to $142.1 million in the first nine months of fiscal 2012 from $108.5 million in the first nine months of fiscal 2011.During the first nine months of fiscal 2012, volume of product shipments increased 24.3% compared to the first nine months of fiscal 2011, which accounted for an increase in revenue of approximately $37.3 million. Carbon fiber sales increased 36.1%, or $30.6 million, to $115.2 million in the first nine months of fiscal 2012 from $84.6 million in the first nine months of fiscal 2011due to increased shipments to wind customers. Technical fiber sales increased 12.6%, or $2.8 million, to $25.1 million in the first nine months of fiscal 2012 from $22.3 million in the first nine months of fiscal 2011 due to increased shipments to aircraft brake customers.  Additionally, the weakening of the Euro during the first nine months of fiscal 2012 resulted in a $3.4 million decrease in total revenue.

The Company's cost of sales increased by 9.4%, or $9.1 million, to $106.7 million in the first nine months of fiscal 2012 from $97.6 million in the first nine months of fiscal 2011. The increase in cost of sales reflected increased sales of 30.9% discussed above and decreased raw material costs as lower cost ACN was used in production.  Carbon fiber cost of sales increased by 15.7%, or $12.1 million, to $89.1 million for the first nine months of fiscal 2012 from $77.0 million for the first nine months of fiscal 2011. The increase in carbon fiber cost of sales reflected increased sales of 36.1% as discussed above and decreased raw material costs as lower cost ACN was used. Technical fiber cost of sales decreased 18.6% or $3.6 million, to $15.9 million for the first nine months of fiscal 2012 from $19.5 million for the first nine months of fiscal 2011 as a result of improved efficiencies and lower cost ACN.

The Company's gross profit increased by $24.4 million, to $35.4 million, or 24.9% of sales in the first nine months of fiscal 2012 from $11.0 million, or 10.1% of sales in the first nine months of fiscal 2011. During the first nine months of 2012, available unused capacity costs decreased to $2.1 million compared to the first nine months of 2011 when gross margin was negatively impacted by $9.8 million of available unused capacity costs. Carbon fiber gross profit percentage increased to 22.6% for the first nine months of fiscal 2012 compared to 9.0% for the first nine months of fiscal 2011. Carbon fiber gross profit increased to $26.1 million from $7.6 million during these respective periods. The increases in carbon fiber gross profit and gross profit percentage resulted primarily from increased production levels with improved sales as we brought our Mexican operation online and increased output in Hungary. We also improved the efficiency of our operations which decreased production costs.   Costs of our primary raw material used in manufacturing, ACN, also decreased by 6.4% from the first nine months of fiscal 2011.  Our gross margins have also benefited from price increases as market demand has increased.  Technical fiber gross profit increased to $9.3 million, or 36.8% of sales, in the first nine months of fiscal 2012 from $2.8 million, or 12.6% of sales, in the first nine months of fiscal 2011. The increases in technical fiber gross profit and margin resulted from increased output in Hungary and lower cost ACN.
 
Application and market development costs were $5.3 million for the first nine months of fiscal 2012 and $6.4 million for the first nine months of fiscal 2011. These costs included product development efforts, product trials and operational improvement design. Targeted emerging applications include automobile components, offshore oil and gas drilling, fire/heat barrier and alternate energy technologies.
 
Selling, general and administrative expenses were $9.8 million in the first nine months of fiscal 2012 and $10.3 million the first nine months of fiscal 2011. The Company recorded $0.8 million and $0.7 million for the cost of employee and director services received in exchange for equity instruments under ASC 718 during the first nine months of fiscal 2012 and fiscal 2011, respectively.
 
Operating income from the first nine months of fiscal 2012 was $20.3 million, an improvement from an operating loss of $5.7 million incurred during the first nine months of fiscal 2011. This improvement resulted primarily from an increase in gross profit of $24.4 million and a decrease of $1.1 million in research and development expenses. Carbon fiber operating income increased to $21.2 million in the first nine months of fiscal 2012 from income of $1.4 million in the first nine months of fiscal 2011. The increase resulted from an increase in gross profit as discussed above.  Operating income from technical fibers increased to $8.3 million in the first nine months of fiscal 2012 from $2.0 million in the first nine months of fiscal 2011. The increase in technical fiber operating income resulted from the increase in gross profit described above.
 
Gain on foreign currency translations was $0.3 million for the first nine months of fiscal 2012, compared to a loss of $1.9 million for the first nine months of fiscal 2011. During the first nine months of fiscal 2012, the Euro weakened and the U.S. dollar strengthened in value against the HUF.  As most of the Company’s Hungarian accounts receivables are denominated in Euros and U.S. dollars, the weakening in value of the Euro and the strengthening in value of the U.S. dollar resulted in a small gain recognized in our Hungarian subsidiary.  During the first nine months of fiscal 2011, the Euro and the U.S. dollar weakened in value against the HUF.  The translation of the Hungarian subsidiary’s financial statements from its functional currency (HUF) to U.S. dollars is not included in determining net income for the period but is recorded in accumulated other comprehensive income (loss) in equity.
 
 
20

 
 
Other expense, net, was $0.8 million in the first nine months of fiscal 2012 compared to $0.4 million in the first nine months of fiscal 2011. Other expense, net consists primarily of loss from the disposal of fixed assets.
 
Gain on liabilities carried at fair value was $0.1 million in the first nine months of fiscal 2012 compared to a gain of $0.6 million in the first nine months of fiscal 2011 (see   “ Liquidity and Capital Resources – Fair Value Measurement of Instruments ").
 
Income tax expense was $1.1 million for the first nine months of fiscal 2012 compared to an expense of $0.5 million for the first nine months of fiscal 2011.  An expense of $1.0 million was incurred related to the local Hungarian municipality tax and $0.1 million was recorded related to U.S. and Mexico minimum tax payments.  During the first quarter of fiscal 2011, the Company recognized a $0.3 million expense as we adjusted our Hungarian effective tax rate to reflect a change to tax law.  The Hungarian tax rate of 10% applies to a tax base up to HUF 500 million (approximately $2.1 million using the June 30, 2012 exchange rate), with a 19% rate continuing to apply to a base exceeding this ceiling. Hungary has also announced that effective for the Company’s fiscal 2013 tax year, losses carried forward from previous years can be used only up to 50% of the tax base.  For the first nine months of fiscal 2011, income tax expense of $0.5 million was incurred related to the local Hungarian municipality tax and U.S. income taxes as well partially offset by a tax benefit of approximately $0.2 million related to an increase in Hungary’s deferred tax position.
 
The foregoing resulted in net income of $18.6 million for the first nine months of fiscal 2012 compared to a loss of $8.1 million for first nine months of fiscal 2011. Similarly, the Company reported income per share of $0.54 and loss per share of $0.24 per share on a basic and diluted basis for the first nine months of fiscal 2012 and 2011, respectively.

Liquidity and Capital Resources
 
The Company believes its cash currently on hand, cash flow from operations, and existing and anticipated credit facilities should be sufficient to fund its identified liquidity needs during the next twelve months.
 
Cash Provided By (Used In) Continuing Operating Activities
 
Operating activities provided $8.3 million of cash for the first nine months of fiscal 2012. Inventory levels used $16.4 million during the first nine months of fiscal 2012 in anticipation of  increased sales levels, including increases in consigned inventory, which represents contractually required finished goods inventory levels for certain key customers.    Cash flows were positively affected by depreciation of $13.3 million for the first nine months of fiscal 2012, which was included in the operating income of $20.3 million.  Increased accounts receivable also used $8.8 million of cash primarily due to increased sales during the first nine months of fiscal 2012.
 
Operating activities used $3.2 million of cash for the first nine months of fiscal 2011. Increased inventory levels in anticipation of higher sales reduced cash by $7.7 million. Cash flows were positively affected by depreciation of $13.1 million for the first nine months of fiscal 2011, which was included in the operating loss of $5.7 million. Accounts receivables increased by $4.5 million during the first nine months of fiscal 2011, reflecting sales growth.  Payables and accrued expenses increased by $2.9 million.
 
Cash Used In Investing Activities
 
Net cash used in investing activities for the first nine months of fiscal 2012 was $17.0 million, which primarily consisted of capital expenditures on existing production lines and new equipment.  Approximately $8.8 million of the decline in property and equipment, net was caused by the decline in value of the HUF, which is the functional currency of our Hungarian operations. The change in property and equipment, net was also impacted by $18.0 million of capital expenditures and depreciation expense of $13.3 million. Capital expenditures included $6.8 million related to the purchase of the building in St. Peters, Missouri and the related move of our prepreg operations.  We expect to continue our capital investment programs in the remainder of fiscal 2012 primarily with respect to prepreg capacity, fabrics capacity and production efficiencies for carbon and technical fibers manufacturing.
 
Net cash used in investing activities for the first nine months of fiscal 2011 was $4.6 million, which consisted of capital expenditures on existing production lines and new equipment. Approximately $10.2 million of the increase in property and equipment, net was caused by the increase in value of the HUF, which is the functional currency of our Hungarian operations. Historically, cash used in investing activities has been expended for equipment additions and the expansion of the Company’s carbon fiber and technical fiber production capacity.
 
     Cash Provided By Financing Activities
 
Net cash provided by financing activities was $21.1 million for the first nine months of fiscal 2012.  During the third quarter, Zoltek Zrt. entered into a $17.1 million term loan secured by the Company’s facilities in Hungary, which loan is guaranteed by the Company.   Zoltek Zrt. will utilize the proceeds of the loan to supplement working capital and other general corporate purposes. The Company also borrowed $10.0 million under its term loan, the proceeds of which were used to repay it former U.S. bank line of credit.
 
Net cash provided by financing activities was $3.9 million for the first nine months of fiscal 2011 resulting from borrowing of credit lines and cash settlement of restricted shares.
 
 
21

 
 
Earnings Per Share
 
In accordance with ASC 260, the Company has evaluated its diluted income (loss) per share calculation. The Company had outstanding warrants and stock options at June 30, 2012 and 2011 which were not included in the determination of diluted loss per share because they were anti-dilutive.

Net income (loss) per share for the three months ended June 30, 2012 and 2011, respectively is as follows (in thousands, except per share amounts):

   
Three months ended June 30,
   
Nine months ended June 30,
 
   
2012
   
2011
   
2012
   
2011
 
Numerators:
                       
Net income (loss)
  $ 5,566     $ (1,461 )   $ 18,607     $ (8,130 )
                                 
Denominators:
                               
Average shares outstanding – basic
    34,355       34,373       34,359       34,382  
Impact of stock options
    59       -       55       -  
Average shares outstanding – diluted
    34,414       34,373       34,414       34,382  
                                 
Basic income (loss) per share
  $ 0.16     $ (0.04 )   $ 0.54     $ (0.24 )
Diluted income (loss) per share
  $ 0.16     $ (0.04 )   $ 0.54     $ (0.24 )
 
 
Hungarian Grant
 
The Hungarian government has pledged a grant of 2.9 billion HUF to Zoltek’s Hungarian subsidiary, which translated at the June 30, 2012 exchange rate, was approximately $12.4 million. The grant has provided a portion of the capital resources necessary to modernize the subsidiary’s facility, establish a research and development center, and support buildup of manufacturing capacity of carbon fibers. As of June 30, 2012, Zoltek’s Hungarian subsidiary has received approximately 2.6 billion HUF ($11.2 million at the June 30, 2012 exchange rate) in grant funding. These funds have been recorded as a liability on the Company’s consolidated balance sheets. The liability is being amortized over the life of the assets procured by the grant funds, offsetting the depreciation expense from the assets into which the proceeds of the grant are invested. As required by the grant, the Company has issued bank guarantees amounting to 120% of the amount of the grant as received.
 
The Hungarian subsidiary may be required to repay all or a portion of the grant if, among other things, the Hungarian subsidiary:  fails to obtain revenue targets; fails to employ an average annual staff of at least 1,200 employees; fails to utilize regional suppliers for at least 45% of its purchases; fails to obtain consent from the Hungarian government prior to selling assets created with grant funds; fails to use grant funds in accordance with the grant agreement; fails to provide appropriate security for the grant; makes or made an untrue statement or supplies or supplied false data in the grant agreement, grant application or during the time of the grant; defaults on its obligations by more than 30 days; withdraws any consents it gave in the grant agreement; or causes a partial or complete failure or hindrance of the project that is the subject of the grant. These targets must be achieved during a five-year measurement period from October 2012 to October 2017, though the Company has received a letter of intent from the Hungarian government to delay the beginning of the five-year measurement period by one year. Although there can be no assurance, the Company anticipates it will comply with the requirements of the grant agreement when the measurement period begins.

 
Financing Activities
 
Hungarian Financing
 
On June 15, 2012, Zoltek’s Hungarian subsidiary (“Zoltek Zrt”) completed an amended credit facility with Raiffeisen Bank Zrt. (the “Lender”) pursuant to which Zoltek Zrt. and the Lender entered into a Credit Facility Agreement, dated as of June 1, 2012 and a Restated and Amended Uncommitted Credit Line Agreement, dated as of June 1, 2012.  Under the credit facility, the Lender agreed to provide Zoltek Zrt.: (1) a term facility in the maximum amount of 13.6 million EUR ($17.1 million at the June 30, 2012 exchange rate) (the “Term Facility”) and (2) a multicurrency overdraft facility in the amount of up to 1.12 billion HUF ($4.8 million at the June 30, 2012 exchange rate) (the “Revolving Facility”).
 
 
22

 
 
The Term Facility is a five-year term loan and bears interest at 4.17%, payable semi-annually.  Principal under the Term Facility is payable semi-annually in equal installments.  The Revolving Facility is a revolving credit facility that expires on March 29, 2013 and has a total commitment of 1.120 billion HUF ($4.8 million at the June 30, 2012 exchange rate) subject to a borrowing base.  In addition to the Term Facility and the Revolving Facility, Zoltek Zrt. has obtained from the lender a bank guaranty in the amount of HUF 3.48 billion ($14.9 million at the June 30, 2012 exchange rate) as required by the Hungarian government grant.  The obligations of Zoltek Zrt. under this credit facility are guaranteed by the Company.
 
This credit facility contains representations and warranties, and contains a requirement that Zoltek Zrt. maintain a minimum current asset ratio and minimum annual EBITDA, along with other covenants.  Zoltek Zrt. had previously maintained a credit facility with the Lender, which expired May 30, 2012 and the facility was replaced with the new facility.
 
US Financing

On March 30, 2012, Zoltek Companies, Inc. entered into a $10 million term loan with Enterprise Bank & Trust (the “Enterprise Loan”) secured by the real property associated with its facilities in the St. Louis, Missouri area.  The Enterprise Loan is a seven-year, secured term loan maturing March 30, 2019. Principal of the Enterprise Loan is payable monthly with a balloon payment due at maturity. The Enterprise Loan bears interest at a one-month LIBOR rate, plus 3%. The Company entered into a swap agreement that fixes the interest rate on the Enterprise Loan at 4.75% per annum. The Loan Agreement contains representations and warranties, and contains a requirement that the Company, on a consolidated basis, maintain minimum fixed charge coverage and leverage ratios, along with other covenants.
 
The Company primarily utilized the proceeds of the Enterprise Loan to repay all outstanding balances under the Company's former U.S. revolving credit facility with BMO Harris Bank N.A.

On April 27, 2012, Zoltek Companies, Inc. entered into a $15 million revolving credit agreement with JPMorgan Chase, N.A., with interest based on LIBOR plus 2.5%, adjusted monthly.  The revolving credit facility is subject to a borrowing base and financial covenants and expires on April 27, 2015.
 
Stock Compensation Expense

The Company has two Long-Term Incentive Plans, under which equity-based awards may be granted, including restricted shares of common stock, performance awards, stock options and stock units. At June 30, 2012, there were an aggregate of 2.0 million shares authorized for issuance under these plans. As of June 30, 2012, approximately 0.4 million and 0.1 million shares remained available for future issuance under the 2008 Employee Long-Term Incentive Plan and the 2008 Directors Long-Term Incentive Plan, respectively. See Note 6 of the Notes to Condensed Consolidated Financial Statements (Unaudited).

New Accounting Pronouncements

See Note 11 of the Notes to Condensed Consolidated Financial Statements (Unaudited).

Item 3.     Quantitative and Qualitative Disclosures About Market Risk
 
Foreign Currency Risk
 
The consolidated balance sheets of the Company's international subsidiaries, Zoltek Zrt. and Zoltek de Mexico, were translated from Hungarian Forints and Mexican Pesos to U.S. dollars, respectively, at the exchange rates in effect at the applicable balance sheet date, while its consolidated statements of operations were translated using the average exchange rates in effect for the periods presented. The related translation adjustments are reported as other comprehensive income (loss) within shareholders' equity. Gains and losses from foreign currency transactions of Zoltek Zrt. are included in other expenses.  The Company views as long-term its investments in Zoltek Zrt. and Zoltek de Mexico. Zoltek Zrt. has a functional currency of the HUF. As a result, the Company is exposed to foreign currency risks related to this investment. The HUF weakened by 8.3% against the U.S. dollar during the first nine months of fiscal 2012. This currency fluctuation caused an increase of $11.0 million in our accumulated other comprehensive loss for the nine months ended June 30, 2012.  The functional currency of Zoltek de Mexico is the U.S. dollar. The Company does not currently employ a foreign currency hedging strategy related to the sales from Hungary or Mexico. Neither Hungary nor Mexico is considered to be a highly inflationary or deflationary economy.
 
As of June 30, 2012, the Company had a long-term loan of $108.0 million to its Zoltek Zrt. subsidiary denominated in U.S. dollars. The potential loss in value of the Company's net foreign currency investment in Zoltek Zrt. resulting from a hypothetical 10% adverse change in quoted foreign currency exchange rate of the HUF against the U.S. dollar at June 30, 2012 and 2011 amounted to $10.8 million and $10.8 million, respectively.  The Company does not expect repayment of the loan in the foreseeable future. As such, the Company considers this loan as a permanent investment.  In addition, Zoltek Zrt. routinely sells its products to customers located primarily throughout Europe in sales transactions that are denominated in foreign currencies other than the HUF. Also, Zoltek Zrt. has debt that is denominated in foreign currencies other than the HUF.
 
As of June 30, 2012, the Company had a long-term loan to its Zoltek de Mexico subsidiary. There is no potential loss in value of the Company's net foreign currency investment in Zoltek de Mexico resulting from an adverse change in quoted foreign currency exchange rate of the Mexican Peso against the U.S. dollar at June 30, 2012 because Zoltek de Mexico’s functional currency is the U.S. dollar.  The Company does not expect repayment of the loan in the foreseeable future. As such, the Company considers this loan as a permanent investment.
 
 
23

 
 
Commodity Price Risk
 
We are exposed to commodity price risk arising from changes in the market price of certain raw materials and other production inputs, such as ACN and utilities.  Due to competition and market conditions, volatile price increases cannot always be passed on to our customers. Management assesses commodity price trends on a regular basis and seeks to adjust purchasing accordingly. The Company does not currently utilize derivative instruments to hedge purchases of commodities.

Interest Rate Risk
 
We are exposed to various market risks, including fluctuations in interest rates. We use interest rate swap agreements to manage our interest costs and reduce our exposure to increases in floating interest rates. Using interest rate swap agreements, we agree to exchange, at specified intervals through 2017, the difference between fixed and variable interest amounts calculated by reference to agreed-upon notional principal amounts.
 
We do not hold or issue derivative instruments for speculative trading purposes. We have an interest rate derivative instrument that has been designated as cash flow hedging instruments. Such instrument effectively converts variable interest payments on certain debt  into fixed payments. For qualifying hedges, realized derivative gains and losses offset related results on hedged items in the consolidated statements of operations. We formally document, designate and assess the effectiveness of transactions that receive hedge accounting.  As of June 30, 2012, there was no cash flow hedge ineffectiveness on our interest rate swap agreement.

*  *  *
Special Note Regarding Forward-Looking Statements
 
This quarterly report includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements.

                 The forward-looking statements contained in this report are inherently subject to risks and uncertainties.  The Company’s actual results could differ materially from those in the forward-looking statements.  The factors that might cause such differences include, among others, our ability to: (1) successfully adapt to recessionary conditions in the global economy and substantial volatility in order rates from our wind energy customers, including our principal customer Vestas Wind Systems; (2) penetrate existing, identified and emerging markets, including entering into new supply agreements with large volume customers; (3) continue to improve efficiency at our manufacturing facilities on a timely and cost-effective basis to meet current order levels of carbon fibers; (4) successfully add new planned capacity for the production of carbon fiber, prepregs and precursor raw materials and meet our obligations under long-term supply agreements; (5) operate profitably; (6) increase or maintain our borrowing at acceptable costs; (7) manage changes in customers’ forecasted requirements for our products; (8) continue investing in application and market development for a range of applications; (9) manufacture low-cost carbon fibers and profitably market them despite fluctuations in raw material and energy costs; (10) successfully operate our Mexican facility to produce acrylic fiber precursor and carbon fibers; (11) successfully continue operations at our Hungarian facility if natural gas supply disruptions occur; (12) successfully prosecute patent litigation; (13) successfully facilitate adoption of our carbon fibers by the auto industry for use in high-volume applications; (14) establish and grow prepreg capacity; and (15) speed development of low-cost carbon fiber sheet molding compounds for the automotive industry pursuant to our global collaborative partnership with Magna Exteriors and Interiors; and (16) manage the risks identified under "Risk Factors" in our filings with the SEC.


*  *  *

Item 4.     Controls and Procedures

Evaluation of Controls and Procedures

As of the end of the period covered by this report, an evaluation was carried out by management, under the supervision and with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended.  The Company’s disclosure controls and procedures are designed to ensure that information required to be disclosed in reports it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.
 
 
24

 
 
Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures as of June 30, 2012, were effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission’s rules and forms.

There has been no change in our internal control over financial reporting during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 
25

 

ZOLTEK COMPANIES, INC.
 
PART II.
OTHER INFORMATION    
Item 1.
Legal Proceedings.    
       
 
None.
   
       
Item 5.
Other Information    
       
 
None.
   
       
Item 6.
Exhibits.    
       
 
See Exhibit Index
   
 
 
26

 
 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Zoltek Companies, Inc.
 
 
(Registrant)
 
     
Date:  August 2, 2012
By:
/s/ ZSOLT RUMY  
   
Zsolt Rumy
 
   
Chief Executive Officer
 
 
 
27

 
 
EXHIBIT INDEX
 
Exhibit Number
Description of Document
   
10.1
Credit Agreement, dated April 27, 2012 by and among Zoltek Companies, Inc., Zoltek Corporation, Zoltek Properties, Inc , Engineering Technology Corporation, Zoltek Automotive, and Zoltek Composite Intermediates LLC, in favor of JPMorgan Chase Bank, N.A. is filed herewith.
   
10.2
Amended Credit Facility Agreement, dated June 1, 2012, between Raiffeisen Bank and Zoltek Zrt., the wholly owned subsidiary of Zoltek Companies,Inc., filed herewith.
   
10.3
Restated and Amended Uncommitted Credit Line Agreement, dated June 1, 2012, between Raiffeisen Bank and Zoltek Zrt., the wholly owned subsidiary of Zoltek Companies,Inc., filed herewith.
   
10.4
Joint and Several Guarantee Agreement, dated June 1, 2012, between Raiffeisen Bank and Zoltek Zrt., the wholly owned subsidiary of Zoltek Companies,Inc., filed herewith.
   
31.1
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended.
   
31.2
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended.
   
32.1
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
   
101.INS**
XBRL Instance
   
101.SCH**
XBRL Taxonomy Extension Schema
   
101.CAL**
XBRL Taxonomy Extension Calculation
   
101.DEF**
XBRL Taxonomy Extension Definition
   
101.LAB**
XBRL Taxonomy Extension Labels
   
101.PRE**
XBRL Taxonomy Extension Presentation
 
** XBRL
information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
 
 
 
28

XNAS:ZOLT Quarterly Report 10-Q Filling

XNAS:ZOLT Stock - Get Quarterly Report SEC Filing of XNAS:ZOLT stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

XNAS:ZOLT Quarterly Report 10-Q Filing - 6/30/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XNAS:ZOLT Quarterly Report 10-Q Filing - 3/31/2012  |  Next: XNAS:ZOOM Zoom Technologies Inc Quarterly Report 10-Q Filing - 3/31/2012